Piattaforma in vitro 3D multiplexed che combina più tessuti umani per test preclinici dei farmaci.
| Date | Round | Amount |
|---|---|---|
| Jan 2026 | Seed Geneva-based FluoSphera raised a CHF 1.15 million seed led by Soulmates Ventures to scale its 3D human organ models that reduce clinical drug failures. | $1.4M |